about the moral implications of placebos within biomedical practice-especially as this pertains to informed consent processes.
How we define the terms 'placebo' and 'placebo effect' is therefore of utmost relevance to understanding the psychotherapy-placebo hypothesis, including its implications for psychotherapy research, training, and good practice. Indeed, unlike clinical medicine, historically there has been scant scholarly attention paid to ethical issues (including informed consent processes) in the clinical delivery of psychotherapy (Blease, 2015a (Blease, , 2015b .
This Special Issue therefore brings together two major research traditions: placebo studies and psychotherapy research. The contributions in this issue present the first, sustained interdisciplinary attempt to focus scholarly attention on the theoretical, empirical, and ethical relationship between psychotherapy and the placebo effect. It is born out of a unique three-day workshop organized at the Brocher Foundation on the shores of Lake Geneva, Switzerland in June 2014: an occasion that brought together psychotherapy researchers, placebo experts, cognitive psychologists, philosophers, and practicing psychotherapists to discussfor the first time at a face-to-face gathering-the relationship between psychotherapy and the placebo effect. As a testimony to the level of stimulating, cross-disciplinary discussion at the event, most the articles in this collection emerged directly out of new collaborations from that meeting.
The Special Issue opens with a background critique of the historical use of the placebo concept in clinical psychotherapy trials (Wampold, Frost, & Yulish, 2016, pp. 108 -120) . This is followed by a theoretical paper that appraises the attempt to control for the placebo effect in clinical psychotherapy studies (Kirsch, Wampold, & Kelley, 2016, pp. 121-131) . The issue moves on to discuss factors that influence the size of the placebo effect in psychotherapy encounters: these include an extensive overview of empirical research on the role of the practitioner-patient relationship in influencing successful therapeutic outcomes (Jensen & Kelley, 2016, pp. 132-145) , a paper on new empirical findings on the role of hypnotic suggestibility in eliciting placebo effects (Sheiner, Lifshitz, & Raz, 2016, pp. 146 -153) , and a discussion of the efficacy paradox, in which treatments that show little benefit over placebo controls may show substantial benefits over treatments that outperform placebos to a greater degree (Walach, 2016, pp. 154 -161) . These contributions are followed by an overview of cutting-edge research into multilevel analyses of placebo and nocebo effects (including their neural correlates and cognitive mechanisms) and a commentary on how these might be harnessed in clinical contexts for the alleviation of symptom relief (Colloca & Benedetti, 2016, pp. 162-174) . The Special Issue closes with a provocative theoretical paper on the moral repercussions of placebo research in psychotherapy, and urges psychotherapists to 'go open' in respect of the placebo effect (Gaab, Blease, Locher, & Gerger, 2016, pp. 175-198) .
We thank the authors for their valuable contributions, and Editor Steven Lynn for his excellent editorial advice. We are confident that this collection of papers will ignite a new, lively debate at the interface of placebo studies and psychotherapy research.
